Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Fate Therapeutics Inc. sell Bank of America Co.

Start price
€6.80
28.03.24 / 50%
Target price
€5.56
28.03.25
Performance (%)
-47.84%
Price
€3.55
26.04.24
Summary
This prediction is currently active. Massive losses of -47.84% have been the result for the SELL prediction by Bank_of_America_Co_. This prediction currently runs until 28.03.25. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w
Fate Therapeutics Inc. -21.195%
iShares Core DAX® 2.594%
iShares Nasdaq 100 3.553%
iShares Nikkei 225® 0.687%
iShares S&P 500 2.209%

Comments by Bank_of_America_Co_ for this prediction

In the thread Fate Therapeutics Inc. diskutieren
Prediction Sell
Perf. (%) -47.84%
Target price 5.558
Change
Ends at 28.03.25

Fate Therapeutics, Inc. (NASDAQ: FATE) had its price target raised by analysts at Bank of America Co. from $2.00 to $6.00. They now have an "underperform" rating on the stock.
Ratings data for FATE provided by MarketBeat